Literature DB >> 7223358

Herpes simplex encephalitis: A serological follow-up study. Synthesis of herpes simplex virus immunoglobulin M, A, and G antibodies and development of oligoclonal immunoglobulin G in the central nervous system.

B Sköldenberg, K Kalimo, A Carlström, M Forsgren, P Halonen.   

Abstract

A solid-phase radioimmunoassay method was used for the detection of herpes simplex virus (HSV) immunoglobulin M (IgM), IgA, and IgG antibodies within the central nervous system in 11 patients with acute HSV encephalitis. Serial cerebrospinal fluid (CSF) and serum specimens were sampled during the observation periods, extending up to 43 months after onset. The clinical diagnosis of HSV encephalitis was confirmed demonstrating virus or virus antigen in the central nervous system in four patients and with significant HSV antibodies in CSF in all the patients. In acute stage CSF HSV antibodies of a significant level were demonstrated in one of four samples taken on days 3--4 after onset, and in samples taken on days 6--8 in five of nine patients. CSF HSV antibodies of a significant and high level were detected in all samples taken from day 10 after onset. Intrathecal production of HSV IgM and IgA antibodies lasted from 7 weeks to 43 months during the observation periods. All patients had persistent intrathecal production of HSV IgG antibodies as well as of oligoclonal IgG during the total observation periods up to 43 months.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7223358

Source DB:  PubMed          Journal:  Acta Neurol Scand        ISSN: 0001-6314            Impact factor:   3.209


  17 in total

1.  Antiviral agents in Alzheimer's disease: hope for the future?

Authors:  Matthew A Wozniak; Ruth F Itzhaki
Journal:  Ther Adv Neurol Disord       Date:  2010-05       Impact factor: 6.570

Review 2.  Keeping it in check: chronic viral infection and antiviral immunity in the brain.

Authors:  Katelyn D Miller; Matthias J Schnell; Glenn F Rall
Journal:  Nat Rev Neurosci       Date:  2016-11-04       Impact factor: 34.870

3.  Is serodiagnosis of herpes simplex encephalitis safe?

Authors:  J G Coghlan; C Monaghan; P A Carney; J H Moran
Journal:  Postgrad Med J       Date:  1987-11       Impact factor: 2.401

4.  Acute viral encephalitis.

Authors:  P E Klapper; M Longson
Journal:  Br Med J (Clin Res Ed)       Date:  1981-12-05

5.  Anti-herpes simplex type 1 activity in IgG subclasses produced systemically and intrathecally in patients with herpes encephalitis.

Authors:  P J Johansson; J Blomberg
Journal:  J Neurol       Date:  1986-10       Impact factor: 4.849

6.  Long-term persistence of intrathecal virus-specific antibody responses after herpes simplex virus encephalitis.

Authors:  B Vandvik; B Sköldenberg; M Forsgren; G Stiernstedt; S Jeansson; E Norrby
Journal:  J Neurol       Date:  1985       Impact factor: 4.849

7.  Protective Humoral Immunity in the Central Nervous System Requires Peripheral CD19-Dependent Germinal Center Formation following Coronavirus Encephalomyelitis.

Authors:  Jeffrey R Atkinson; Cornelia C Bergmann
Journal:  J Virol       Date:  2017-11-14       Impact factor: 5.103

8.  Diagnosis of herpes simplex virus encephalitis by detection of virus-specific immunoglobulins A and G in serum and cerebrospinal fluid by using an antibody-capture enzyme-linked immunosorbent assay.

Authors:  A M van Loon; J T van der Logt; F W Heessen; B Postma; M F Peeters
Journal:  J Clin Microbiol       Date:  1989-09       Impact factor: 5.948

9.  Cryptococcal meningoencephalitis: intrathecal immunological response.

Authors:  L La Mantia; A Salmaggi; L Tajoli; D Cerrato; E Lamperti; A Nespolo; G Bussone
Journal:  J Neurol       Date:  1986-11       Impact factor: 4.849

10.  Progression from IgD+ IgM+ to isotype-switched B cells is site specific during coronavirus-induced encephalomyelitis.

Authors:  Timothy W Phares; Krista D DiSano; Stephen A Stohlman; Cornelia C Bergmann
Journal:  J Virol       Date:  2014-05-28       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.